Product Information

ERYTHROMYCIN DR 333 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $3.5825 per EA under NDC 13668058730. Its NADAC has been published 94 times since Nov 6, 2024.

FDA first approved this application on Jul 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN DR 333 MG TABLET

ERYTHROMYCIN
$3.5825per EA

Strength

333 mg/1

NDC

13668058730

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211975

FDA Approved

7/26/2021

TE Code

AB

On Market Since

10/21/2024

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN DR 333 MG TABLET has been published 94 times since Nov 6, 2024, and over the history we have for it it has risen 35.1%. The table below summarizes its recorded NADAC range and movement.

Current price$3.5825 per EA
All-time high$3.9058 (Dec 11, 2024)
All-time low$2.6517 (Nov 6, 2024)
52-week high$3.7275
52-week low$3.3321
Median price$3.5900
Average price$3.5694
Largest weekly change+47.3% (Nov 20, 2024)
Weeks tracked94
Tracking sinceNov 6, 2024

Price History

1W

-2.5%

1M

-2.5%

3M

+5.3%

6M

+4.3%

1Y

+2.5%

3Y

N/A

5Y

N/A

All

+35.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ERYTHROMYCIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN DR 333 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 333 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $3.5825 per EA (NDC 13668058730), effective Aug 19, 2026.

How has the price of ERYTHROMYCIN DR 333 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has risen 35.1%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 333 MG TABLET?

Since Nov 6, 2024, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has ranged from a low of $2.6517 (Nov 6, 2024) to a high of $3.9058 (Dec 11, 2024), with a median of $3.5900 per EA.

Are there cheaper alternatives to ERYTHROMYCIN DR 333 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ERYTHROMYCIN DR 333 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ERYTHROMYCIN DR 333 MG TABLET?

ERYTHROMYCIN DR 333 MG TABLET (NDC 13668058730) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.